CAS 918127-53-4

Tigatuzumab

CAS: 918127-53-4

Tigatuzumab (CS-1008) is a humanized monoclonal antibody targeting DR5 and is a TRAIL-R2 agonist with antitumor activity that induces apoptosis in cancer cells.

Reinheit: 98.9% (SDS-PAGE); 96.6% (SEC-HPLC) - 98.9% (SDS-PAGE); 96.6% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 144.63 kDa

Ref: TM-T76793

Tigatuzumab

CAS: 918127-53-4

Anti-TNFRSF10B (TRAIL-R2) humanized monoclonal antibody, cancer treatment

Ref: 3D-CLA1180